BofA upgrades Pfizer to buy, says profits from Covid treatments provide upside for stock

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters

The big pandemic breakthroughs for Pfizer should help the company fund further research in other areas and boost its stock, according to Bank of America.

More In Street Calls

CNBC ProHere are Tuesday's biggest analyst calls of the day: Rivian, Amazon, Apple, AMD, Maxar, Fisker & more
CNBC ProBank of America downgrades space stock Maxar, sees 14% downside
CNBC ProUBS downgrades HR software stock Workday, citing recession fears